Subscription Info

Thank you for your interest in NymbleInvestor.com.

NymbleInvestor.com published a daily market newsletter called the Daily Report from May 13, 1999 to October 15, 2001. During that time, the NymbleInvestor Research Team put together an impressive performance record despite the extraordinary market turbulence. Using a primarily long-side strategy (95% long, 5% short) to reflect the attitudes of our subscriber base, we beat the NASDAQ Composite by over 78 percentage points, the S&P-500 by over 64 percentage points, the Dow Jones Industrial Average by over 60 points, and the Russell 2000 by over 49 points.

The same Research Team that put up those performance numbers has picked up and moved addresses. After taking a long, hard look at where the stock market was moving and listening to our Subscribers, we decided to refocus our efforts on long term investments in the biotechnology and medical device sector.

The NymbleInvestor.com Research Team is proud to present:

The NymbleInvestor Biotech Monthly (NIBM) and the new web site, BiotechMonthly.com, help investors understand the ins and outs of investing in the biotechnology market sector. The monthly NIBM Newsletter focuses on one company or sub-sector and explains it in terms new biotech investors can understand and with a level of detail that will satisfy experienced biotech investors. We supplement that with the twice-monthly NIBM Update and our special NIBM Alerts.

We invite you to visit our news site and see what the same research team that clobbered the major market averages over the most volatile 29 months in market history is up to. We have a sample NIBM Newsletter and a sample NIBM Update you can read for free.

Thank you again for your interest in NymbleInvestor.com. Now that we are no longer publishing to this site, we hope to see you over at BiotechMonthly.com.